Biomarin Pharmaceutical Inc at JPMorgan US All Stars Conference (Virtual) Transcript
All right. Welcome, everyone, to the 2021 JPMorgan U.S. All Stars Conference. My name is Cory Kasimov. I'm a senior biotech analyst here at JPMorgan. And it's my pleasure to be hosting our next session with BioMarin. As you can see here to represent the company are CEO, J.J. Bienaimé; and CFO, Brian Mueller. I thank you both very much for being here with us today.
Before I turn things over to J.J. for a brief intro, just let me remind everybody that you can participate in our discussion here by asking a question either by clicking the blue Ask a Question button on your portal or, alternatively, you can send me an e-mail as well, and I'll work it into the conversation.
So with that, J.J., let me hand things over to you for a quick intro.
Yes. Thank you, Cory. So we appreciate the opportunity to speak with you today. We see that with nearly 3 quarters of 2021
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
